Also, synthetic ligands are widely used in clinical practice – for example, fibrates (PPARα ligands) are recommended in the dyslipidemic state (hypertriglyceridemia) and thiazolidinediones (PPARγ agonists) are used in the treatment of diabetes mellitus [26-29]. This evidence concerns the gene PPARA and diabetes mellitus.